Tenderwize
Back to tender search

Open house rebate agreements Abatacept, ATC L04AA24

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 03, 2028 · 625 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Abatacept, ATC L04AA24

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or volume is provided. The actual business volume under the agreement is unknown and may be very low.

The agreement automatically becomes void if a nationwide or regional rebate contract for the same substance is conclude...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Non-exclusive rebate agreements for Abatacept (ATC L04AA24) as per § 130a Abs. 8 SGB V
  • Standardized contract terms, not individually negotiable
Show full summary

Open-house model for non-exclusive rebate agreements on Abatacept (ATC L04AA24) by AOK Bayern. Any eligible pharmaceutical company can conclude a standard contract without competitive selection. Contract runs from 01 July 2026 to 30 June 2028. Rolling entry with monthly cutoffs; final deadline for contract conclusion is 03 May 2028. No estimated value or volume is provided.

Risks

No estimated value or volume is provided. The actual business volume under the agreement is unknown and may be very low.

The agreement automatically becomes void if a nationwide or regional rebate contract for the same substance is conclude...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Contract and annex must be signed by an authorized representative (proof of authority required via commercial register extract or power of attorney)

Eligibility

  • Only pharmaceutical companies are eligible to participate

Administrative

  • Must submit a signed declaration of reliability

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house rebate agreements Abatacept, ATC L04AA24

Non-exclusive rebate agreement for the active substance Abatacept. The contract is a standard, non-negotiable agreement offered to all interested pharmaceutical companies meeting eligibility criteria. The contract can be terminated with one month's notice. It automatically becomes void if a nationwide or region-specific rebate contract for the same substance is concluded via an open procedure.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Deadline

Deadline May 03, 2028

Procurement Details

Publication date
17 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
336029-2026

Documents (2)

Similar tenders